All lobbying filings

FEDERAL HEALTH POLICY STRATEGIES

Lobbying for PFIZER · Pharmaceutical Company

Filing Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 18, 2025

Income

$60,000.00

What the client paid this registrant for the period.

Client based in

New York

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Implementation of the drug pricing provisions in the Inflation Reduction Act Drug pricing and prescription digital therapeutics

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.